Elsevier

Clinical Immunology Communications Template

Write in a clean editor, then format for Clinical Immunology Communications in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Clinical Immunology Communications format

Clinical Immunology Communications is a peer-reviewed journal published by Elsevier, covering SARS-CoV-2 and COVID-19 Research, Immunodeficiency and Autoimmune Disorders, COVID-19 Clinical Research Studies.

PublisherElsevier
Reference styleNumbered (Elsevier)
Numbered — [1], [2] in the text
[1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Immunology Communications 12 (2023) 45–58.

Formats any DOI in Clinical Immunology Communications style. No sign-up.

Publishes research inSARS-CoV-2 and COVID-19 Research Immunodeficiency and Autoimmune Disorders COVID-19 Clinical Research Studies Immune Cell Function and Interaction Cancer Immunotherapy and Biomarkers
ISSN2772-6134
Citation impact (2-yr)0.97
h-index10
i10-index11
Total citations375
Article processing charge$1,750
Open accessYes
Top institutions publishing hereUmm al-Qura University
Journal websitewww.journals.elsevier.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Clinical Immunology Communications per year

13
2021
32
2022
28
2023
20
2024
25
2025

Citation impact of Clinical Immunology Communications by publication year

87
2021
132
2022
88
2023
29
2024
27
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Clinical Immunology Communications

The “original antigenic sin” and its relevance for SARS-CoV-2 (COVID-19) vaccination

Ger T. Rijkers, Frans J. van Overveld · 12 Oct 2021

Imprinting of the specific molecular image of a given protein antigen into immunological memory is one of the hallmarks of immunity. A later contact with a related, but different antigen should not trigger the memory response (because the produced antibodies would not be effective). The preferential expansion of cross-reactive antibodies, or T-lymphocytes for that matter,…

Aptamer: A theranostic approach towards breast cancer

Shubhi Rana, Deepti Kaushik, Aprajita Singh et al. · 3 Jun 2023

Breast cancer has a heavy toll on the world's health, both in terms of morbidity and death. For women aged 35 to 54, it is the primary cause of mortality. In addition, over the preceding 2 decades, the mortality rate has not decreased noticeably. Early diagnosis and detection are still essential for enhancing patient outcomes…

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?

Zafran Khan, Ubaid Ahmad, Daniya Ualiyeva et al. · 23 Dec 2021

SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19), an infectious condition that can present none or one or more of these symptoms: fever, cough, headache, sore throat, loss of taste and smell, aches, fatigue and musculoskeletal pain. For the prevention of COVID-19, there are vaccines available including those developed by Pfizer, Moderna, Sinovac, Janssen, and AstraZeneca. Recent…

Daily oral vitamin D3 without concomitant therapy in the management of psoriasis: A case series

Renu Mahtani, Pradeep M.K. Nair · 10 Jan 2022

Evidence suggests vitamin D3 resistance with gene polymorphisms related to its metabolism to have a potential role in the patho-prognosis of psoriasis. We report 6 cases of psoriasis treated with daily oral Vitamin D3 (25 hydroxy cholecalciferol) in doses ranging from 30,000 IU to 60,000 IU over a period of 2 to 6 months and…

Identification and functional analysis of exosomal miR-16-5p, miR-6721-5p, and miR-486-5p associated with immune infiltration for potential vitiligo theranostics

Abhimanyu Thakur, Lifan Liang, Deepjyoti Ghosh et al. · 27 Aug 2022

Vitiligo is an autoimmune disorder, which is characterized by the chronic loss of melanocytes and subsequent lack of melanin from the skin or hair or both. The resultant depigmentation state of the skin causing irregular white patches deteriorates the vitiligo patients’ quality of life by major stigmatizing psychological impact. Despite tremendous studies for the past…

Clinical Immunology Communications template — frequently asked questions

How do I write a paper in the Clinical Immunology Communications format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Clinical Immunology Communications template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Clinical Immunology Communications use?
Clinical Immunology Communications uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Immunology Communications 12 (2023) 45–58.
Do I need to know LaTeX to submit to Clinical Immunology Communications?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready Clinical Immunology Communications document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Clinical Immunology Communications template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Clinical Immunology Communications format with correct headings, figures, tables, and numbered citations.
Who publishes Clinical Immunology Communications?
Clinical Immunology Communications is a multidisciplinary journal published by Elsevier. DocuGuru's Clinical Immunology Communications template matches Elsevier's official submission format.
Can I export a submission-ready Clinical Immunology Communications PDF?
Yes — DocuGuru produces a PDF built with the official Clinical Immunology Communications template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the Clinical Immunology Communications template cost?
You can start writing in the Clinical Immunology Communications template for free. Exporting the final submission-ready Clinical Immunology Communications PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Clinical Immunology Communications template